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Abstract:
Kombucha is a fermented tea beverage produced through use of a symbiotic
culture of bacteria and yeast (SCOBY). The purported health benefits of this drink
are being assessed through the use of an assay simulating breakdown of starches in
the mouth.1 Analysis with spectrophotometry at 540 nm for porcine pancreas
amylase using 0.100 mg/mL reported a Km of 0.440 mg/mL and Vmax of 0.00451
mg/min. Breakdown of starches was compared to a standard using maltose for
comparison.2 Kombucha inhibition using IC50 inhibition analysis with a dose
response curve of dilutions determined a value of 6.70x10-3 mL. Further IC50
analysis was performed using pH adjusted Kombucha and black tea samples
determined values of 7.24x10-1 mL and 6.92x10-4 mL respectively. Using the Gallic
Acid Equivalence method, black tea was prepared with similar phenolic
concentration to that used in Kombucha during the fermentation process. In
adjusting the pH of Kombucha and black tea samples, an acidified solution
demonstrated the highest inhibitory function on pancreatic amylase. This data
provides relevant information related to the absorption of starches in the mouth
during intake of the beverage. The slowed breakdown of carbohydrates to
monosaccharides could be pertinent in the overall health and digestive effects of
Kombucha during consumption.3
Introduction:
Kombucha has been utilized as a fermented tea beverage for hundreds of
years, originally in China before spreading to the rest of the world. With this
beverage came copious amounts of proposed health claims and medicinal
benefits.1,5 Kombucha contains a tea source generally composed of black or green
tea in a sucrose solution that is fermented with a symbiotic culture of bacteria and
yeast (SCOBY). This effectively creates a bubbly, fermented drink with high
antioxidant levels in an acidic environment (pH ~2.68 for the commercial
Kombucha studied) containing live cultures of bacteria.
During the first step of human digestion, starches are broken down in the
mouth by two essential enzymes, human salivary α-amylase and α-glucosidase. This
study focused on the degradation of dietary starches into glucose and maltose by αamylase. This process influences the absorption of carbohydrates and inhibition of
amylase can reduce the effects of hyperglycemia post food intake.
These inhibitory effects are commonly seen in phenolics and certain
antioxidant structures have been linked to varying levels of inhibition in amylase.3
Fruits containing large concentrations of phenolic containing compounds such as
tannins in strawberry and raspberry extracts are known to promote α-amylase
inhibition, thereby affecting the starch digestion ocurring.4 Acids are also known
inhibitors of enzymes through their ability to manipulate side chain and amino acid
structures of intramolecular forces within a compound, affecting the substrate and
binding site interaction.
Experimental Methods:

Initial laboratory procedure utilized an Enzymatic Assay of α-amylase.2
Porcine pancreas amylase was substituted as a suitable reagent for the assay with a
starch substrate. The enzyme was prepared initially to 1.0 unit/mL. A standard of
maltose was used to correlate freed sugars to the breakdown of starch by pancreatic
amylase. Optimization of the assay involved a 10-fold dilution of the pancreatic
amylase in order to fully saturate the enzyme. Inclusion of varying inhibition
sources were added directly to the substrate samples before the enzymatic reaction
was initiated. IC50 curves were constructed in replicate with controls and
background data performed in parallel to each data set. A dose-response curve
using the program Kaleidagraph was constructed for analysis of IC50 data.
Incubation time was increased to 5 minutes. Due to the glycosides contained in the
KT itself, background data using amylase with no starch was used for adjustments
and allowed for analysis of enzyme activity due solely to the interaction of the
starch substrate. Colorimetric analysis was performed using Spectrophotometry at
540 nm. G.T.’s original Kombucha was used for all Kombucha dilutions and tea
solutions were constructed using a Gallic Acid Equivalence (GAE) method.6 Brewed
black tea was diluted to contain the same concentration of phenolics as the original
KT solution. pH adjusted solutions of tea and Kombucha used negligible volumes of
NaOH and Acetic Acid for adjustments.
Results:
After optimizing the pancreatic amylase assay, the following data was used for
determination of the enzyme binding constant.
Figure A.

The following IC50 curves were then plotted using a variety of inhibitors with
adjusted pH values as described on Table 1.
Figure B.
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Figure C.
Inhibition by Kombucha
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A table of values was constructed demonstrating the pH value correlated to IC50
concentration determined by dose-curve analysis.
Table 1.
Inhibitor

pH IC50

R2

G.T.'s Original Kombucha 2.68 6.70x10-3 mL/U amylase 0.99
G.T.'s Kombucha
7.00 7.24x10-1 mL/U amylase 0.96
GAE Black Tea
5.06 significant activity
-4
Black Tea
2.68 6.92x10 mL/U amylase 0.96
Acetic Acid
2.40 <<2.50x10-4 mL/U amylase Discussion:
Using starch concentrations ranging from 0 to 5 mg/mL, a Km value of 0.441
mg/mL was determined. This Km value was used to setup an IC50 system testing the
inhibition capacity of Kombucha and black tea. Figure C shows the IC50 curves for
the original KT solution and the pH adjusted solution, exhibiting less inhibition in
comparison. The original black tea shown in Figure D. showed no inhibition, but
increased inhibition when the pH was lowered with acetic acid. This value
demonstrates more inhibition than the original Kombucha beverage likely due to
the presence of acetic acid to achieve a similar pH. Figure B. relates the inhibition
due to acetic acid, a possible biproduct of the fermentation process, to the
Kombucha and tea solutions. The low activity levels of acetic acid with amylase

could demonstrate some contribution of the inhibition found in the original
Kombucha, however more acids must be produced in biotransformation of the
molecules present during the fermentation process to exhibit the trend seen in
Figure B.
Conclusion:
Kombucha was shown as a significant inhibitor of pancreatic amylase, largely
due to acidic components present. Inhibition by Kombucha contrasted with both the
black tea and acetic acid inhibition trends indicating transformation of the
molecular composition during fermentation. Significant inhibition in varying
solutions was demonstrated in highly acidified pH levels overall. Similar to other
amylase inhibitors, use of Kombucha as a product limiting carbohydrate absorption
may contribute to proposed health benefits and regulation of hyperglycemia.
Kombucha is desirable in the health market for this benefit in addition to probiotic
and antioxidant properties.
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